Skip to main content
SpringerLink
Log in

Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1

Review

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Clinical and genetic understanding of chromaffin tumors has been greatly enhanced in the last few years. Although some pheochromocytoma genes may still be unknown, the role of RET, VHL, SDHB, SDHD and NF1 genes is unequivocal and phenotypes are also being better characterized. The loss of function of VHL and NF1 genes can lead to a variety of tumors including phechromocytoma and their mechanism of action is under intensive investigation. Many different mutations are responsible for VHL gene inactivation but only missense mutations have been described so far in families with pheochromocytoma. Because of its large size extensive mutation analysis of the NF1 gene has seldom been performed, and mutations have only been identified in about 15% of patients. Several point mutations have been found in exon 31. Differences in pheochromocytoma phenotype in VHL or NF1 are not very pronounced, but it may be of some interest to consider the two groups separately. In VHL, pheochromocytoma has an earlier onset than in sporadic forms, it is often multiple, and malignancy is less frequent. The mean age of diagnosis is 28 years, the youngest patient being 5 years old. In NF1 patients pheochromocytoma phenotype is similar to sporadic forms. The mean age of pheochromocytoma onset is 42 years; 84% of patients have solitary adrenal tumors, 9.6% have bilateral adrenal disease and 6.1% have ectopic pheochromocytomas; malignant pheochromocytomas were identified in 11.5% of the cases. The group of pheochromocytoma susceptibility genes includes, along with the tumor suppressor genes VHL and NF1, the proto-oncogene RET and the genes encoding succinate dehydrogenase subunit D and succinate dehydrogenase subunit B. Whether there is a common pathway among these different genes is still a matter of debate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. CA Koch K Pacak GP. Chrousos (2002) ArticleTitleThe molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors J Clin Endocrinol Metab 87 IssueID12 5367–84 Occurrence Handle10.1210/jc.2002-021069 Occurrence Handle1:CAS:528:DC%2BD38XpslWntr4%3D Occurrence Handle12466322

    Article  CAS  PubMed  Google Scholar 

  2. O Gimm M Armanios H. Dziema et al. (2000) ArticleTitleSomatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma Cancer Res 60 IssueID24 6822–5 Occurrence Handle1:CAS:528:DC%2BD3MXjsVKrsQ%3D%3D Occurrence Handle11156372

    CAS  PubMed  Google Scholar 

  3. HP Neumann B Bausch SR. McWhinney et al. (2002) ArticleTitleGerm-line mutations in nonsyndromic pheochromocytoma N Engl J Med 346 IssueID19 1459–66 Occurrence Handle10.1056/NEJMoa020152 Occurrence Handle1:CAS:528:DC%2BD38XjsVynsLc%3D Occurrence Handle12000816

    Article  CAS  PubMed  Google Scholar 

  4. G Opocher F Schiavi A. Vettori et al. (2003) ArticleTitleFine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma Clin Endocrinol (Oxf) 59 IssueID6 707–15 Occurrence Handle10.1046/j.1365-2265.2003.01910.x Occurrence Handle1:STN:280:DC%2BD2c%2Fpt1Cisg%3D%3D

    Article  CAS  Google Scholar 

  5. O Gimm CA Koch A. Januszewicz et al. (2004) ArticleTitleThe genetic basis of pheochromocytoma Front Horm Res 31 45–60 Occurrence Handle1:CAS:528:DC%2BD2cXptVCh Occurrence Handle14674304

    CAS  PubMed  Google Scholar 

  6. HP Neumann C Pawlu M. Peczkowska et al. (2004) ArticleTitleDistinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations JAMA 25 IssueID292(8) 943–51

    Google Scholar 

  7. F Chen T Kishida M Yao SG. Blum et al. (1995) ArticleTitleGermline mutations in the von Hippel–Lindau disease tumor suppressor gene: correlations with phenotype Hum Mutat 5 66–75 Occurrence Handle1:CAS:528:DyaK2MXkt1ekurk%3D Occurrence Handle7728151

    CAS  PubMed  Google Scholar 

  8. HPH Neumann DP Berger et al. (1993) ArticleTitlePheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel–Lindau disease N Engl J Med 329 1531–8 Occurrence Handle10.1056/NEJM199311183292103 Occurrence Handle1:STN:280:ByuD3MbmsVY%3D Occurrence Handle8105382

    Article  CAS  PubMed  Google Scholar 

  9. B Zbar T Kishida F. Chen et al. (1996) ArticleTitleGermline mutations in the Von Hippel–Lindau disease (VHL) gene in families from North America, Europe, and Japan Hum Mutat 8 348–57 Occurrence Handle10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3 Occurrence Handle1:CAS:528:DyaK2sXisFKqtQ%3D%3D Occurrence Handle8956040

    Article  CAS  PubMed  Google Scholar 

  10. PA Crossey FM Richards K. Foster et al. (1994) ArticleTitleIdentification of intragenic mutations in the von Hippel–Lindau disease tumour suppressor gene and correlation with disease phenotype Hum Mol Genet 3 1303–8 Occurrence Handle1:CAS:528:DyaK2cXlslWqtrs%3D Occurrence Handle7987306

    CAS  PubMed  Google Scholar 

  11. F Chen L Slife T. Kishida et al. (1996) ArticleTitleGenotype–phenotype correlation in von Hippel–Lindau disease: identification of a mutation associated with VHL type 2A J Med Genet 33 716–7 Occurrence Handle1:CAS:528:DyaK28Xltleqtrs%3D Occurrence Handle8863170

    CAS  PubMed  Google Scholar 

  12. MM Ritter A Frilling PA. Crossey et al. (1996) ArticleTitleIsolated familial pheochromocytoma as a variant of von Hippel–Lindau disease J Clin Endocrinol Metab 81 1035–7 Occurrence Handle10.1210/jc.81.3.1035 Occurrence Handle1:CAS:528:DyaK28Xhs1agsLw%3D Occurrence Handle8772572

    Article  CAS  PubMed  Google Scholar 

  13. BU Bender C Altehofer A. Januszewicz et al. (1997) ArticleTitleFunctioning thoracic paraganglioma: association with Von Hippel–Lindau syndrome J Clin Endocr Metab 82 3356–60 Occurrence Handle10.1210/jc.82.10.3356 Occurrence Handle1:CAS:528:DyaK2sXmslOhsLg%3D Occurrence Handle9329368

    Article  CAS  PubMed  Google Scholar 

  14. FJ Hes JW Hoppener CJ. Lips (2003) ArticleTitleClinical review 155: Pheochromocytoma in Von Hippel–Lindau disease J Clin Endocrinol Metab 88 IssueID3 969–74 Occurrence Handle10.1210/jc.2002-021466 Occurrence Handle1:CAS:528:DC%2BD3sXit1egtLY%3D Occurrence Handle12629069

    Article  CAS  PubMed  Google Scholar 

  15. G Eisenhofer MM Walther T-T. Huynh et al. (2001) ArticleTitlePheochromocytomas in von Hippel–Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes J Clin Endocr Metab 86 1999–2008 Occurrence Handle10.1210/jc.86.5.1999 Occurrence Handle1:CAS:528:DC%2BD3MXjs1Omsbs%3D Occurrence Handle11344198

    Article  CAS  PubMed  Google Scholar 

  16. WG Kaelin SuffixJr. (2002) ArticleTitleMolecular basis of the VHL hereditary cancer syndrome Nat Rev Cancer 2 IssueID9 673–82 Occurrence Handle10.1038/nrc885 Occurrence Handle1:CAS:528:DC%2BD38Xmslamsrg%3D Occurrence Handle12209156

    Article  CAS  PubMed  Google Scholar 

  17. MA Hoffman M Ohh H. Yang et al. (2001) ArticleTitleVon Hippel–Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF Hum Mol Genet 10 IssueID10 1019–27 Occurrence Handle10.1093/hmg/10.10.1019 Occurrence Handle1:CAS:528:DC%2BD3MXjslyqtLo%3D Occurrence Handle11331612

    Article  CAS  PubMed  Google Scholar 

  18. BU Bender M Gutsche S. Glasker et al. (2000) ArticleTitleDifferential genetic alterations in von Hippel–Lindau syndrome-associated and sporadic pheocromocytomas J Clin Endocrinol Metab 85 IssueID12 4568–74 Occurrence Handle10.1210/jc.85.12.4568 Occurrence Handle1:CAS:528:DC%2BD3MXis1ClsQ%3D%3D Occurrence Handle11134110

    Article  CAS  PubMed  Google Scholar 

  19. CE Stebbins WG Kaelin SuffixJr NP. Pavletich (1999) ArticleTitleStructure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function Science 284 IssueID5413 455–61 Occurrence Handle10.1126/science.284.5413.455 Occurrence Handle1:CAS:528:DyaK1MXisFOksrY%3D Occurrence Handle10205047

    Article  CAS  PubMed  Google Scholar 

  20. T Jacks TS Shih EM. Schmitt et al. (1994) ArticleTitleTumour predisposition in mice heterozygous for a targeted mutation in Nf1 Nat Genet 7 IssueID3 53–61 Occurrence Handle10.1038/ng0794-353

    Article  Google Scholar 

  21. MM Walther J Herring E. Enquist et al. (1999) ArticleTitleVon Recklinghausen’s disease and pheochromocytomas J Urol 162 IssueID5 1582–6 Occurrence Handle10.1097/00005392-199911000-00003 Occurrence Handle1:STN:280:DyaK1Mvlt1GjsQ%3D%3D Occurrence Handle10524872

    Article  CAS  PubMed  Google Scholar 

  22. ME Zoller B Rembeck A. Oden et al. (1997) ArticleTitleMalignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population Cancer 79 IssueID11 2125–31 Occurrence Handle10.1002/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N Occurrence Handle1:STN:280:ByiA383ls1w%3D Occurrence Handle9179058

    Article  CAS  PubMed  Google Scholar 

  23. JM Friedman J Arbiser JA. Epstein et al. (2002) ArticleTitleCardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force Genet Med 4 105–11 Occurrence Handle1:STN:280:DC%2BD38vitlShsQ%3D%3D Occurrence Handle12180143

    CAS  PubMed  Google Scholar 

  24. G Lama L Graziano E. Calabrese et al. (2004) ArticleTitleBlood pressure and cardiovascular involvement in children with neurofibromatosis type 1 Pediatr Nephrol 19 413–8 Occurrence Handle14991390

    PubMed  Google Scholar 

  25. DH Gutmann JL Cole WJ. Stone et al. (1994) ArticleTitleLoss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I Genes Chrom Cancer 10 IssueID1 55–8 Occurrence Handle1:STN:280:ByuA3s7js1Y%3D Occurrence Handle7519874

    CAS  PubMed  Google Scholar 

  26. W Xu LM Mulligan MA. Ponder et al. (1992) ArticleTitleLoss of NF1 alleles in pheochromocytomas from patients with type I neurofibromatosis Genes Chrom Cancer 4 IssueID4 337–42 Occurrence Handle1:CAS:528:DyaK2MXlsFWgtLo%3D Occurrence Handle1377942

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology Unit, Department of Medical and Surgical Sciences, University of Padova, Via Ospedale 105, 35128, Padova, Italy

    Giuseppe Opocher, Pierantonio Conton, Francesca Schiavi, Beatrice Macino & Franco Mantero

Authors
  1. Giuseppe Opocher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierantonio Conton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Schiavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Beatrice Macino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Franco Mantero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Opocher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Opocher, G., Conton, P., Schiavi, F. et al. Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1. Familial Cancer 4, 13–16 (2005). https://doi.org/10.1007/s10689-004-6128-y

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-004-6128-y

Keywords

Search

Navigation